BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25637040)

  • 1. Cardiovascular prevention in the cancer survivor.
    Chen CL
    Curr Atheroscler Rep; 2015 Mar; 17(3):484. PubMed ID: 25637040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
    O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cardiovascular toxicity in the older oncology patient population.
    Findlay SG; Gill JH; Plummer R; DeSantis C; Plummer C
    J Geriatr Oncol; 2019 Sep; 10(5):685-689. PubMed ID: 30733001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organization and implementation of a cardio-oncology program.
    Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
    Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced cardiotoxicity in children.
    Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease.
    Kim L; Loccoh EC; Sanchez R; Ruz P; Anaba U; Williams TM; Slivnick J; Vallakati A; Baliga R; Ayan A; Miller ED; Addison D
    Curr Cardiol Rep; 2020 Sep; 22(11):151. PubMed ID: 32964267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
    Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
    Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors.
    Sadurska E
    Pediatr Cardiol; 2015 Aug; 36(6):1112-9. PubMed ID: 25939787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
    Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac complications in childhood cancer survivors treated with anthracyclines.
    Franco VI; Lipshultz SE
    Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivorship: adult cancer survivors.
    Ganz PA
    Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives.
    Cautela J; Lalevée N; Ammar C; Ederhy S; Peyrol M; Debourdeau P; Serin D; Le Dolley Y; Michel N; Orabona M; Barraud J; Laine M; Bonello L; Paganelli F; Barlési F; Thuny F
    Int J Cardiol; 2016 Dec; 224():366-375. PubMed ID: 27673693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians.
    Johnson CB; Sulpher J; Stadnick E
    Curr Opin Cardiol; 2015 Mar; 30(2):197-204. PubMed ID: 25574894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cardiovascular health in adult cancer survivors.
    Naaktgeboren WR; Linschoten M; de Graeff A; V Rhenen A; Cramer MJ; Asselbergs FW; Maas AHEM; Teske AJ
    Maturitas; 2017 Nov; 105():37-45. PubMed ID: 28583397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in the Cardio-Oncology Clinic.
    Hassen LJ; Lenihan DJ; Baliga RR
    Heart Fail Clin; 2019 Oct; 15(4):487-495. PubMed ID: 31472884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced cardiomyopathy.
    Higgins AY; O'Halloran TD; Chang JD
    Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.